4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-23-033007
Director acquired 9,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KARBE FRANK Director | 2023-05-25 | Grant or award | +9,000 | 9,000 | D | ||
| Derivatives | |||||||
| KARBE FRANK Director | 2023-05-25 | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | D | ||
Loading xslF345X04/doc4.xml…